Department of Pathology, Harvard Medical School, Immune Disease Institute and Children's Hospital, Boston, MA 02115, USA.
EMBO J. 2010 Feb 3;29(3):666-79. doi: 10.1038/emboj.2009.367. Epub 2009 Dec 24.
We report the structure of an integrin with an alphaI domain, alpha(X)beta(2), the complement receptor type 4. It was earlier expected that a fixed orientation between the alphaI domain and the beta-propeller domain in which it is inserted would be required for allosteric signal transmission. However, the alphaI domain is highly flexible, enabling two betaI domain conformational states to couple to three alphaI domain states, and greater accessibility for ligand recognition. Although alpha(X)beta(2) is bent similarly to integrins that lack alphaI domains, the terminal domains of the alpha- and beta-legs, calf-2 and beta-tail, are oriented differently than in alphaI-less integrins. Linkers extending to the transmembrane domains are unstructured. Previous mutations in the beta(2)-tail domain support the importance of extension, rather than a deadbolt, in integrin activation. The locations of further activating mutations and antibody epitopes show the critical role of extension, and conversion from the closed to the open headpiece conformation, in integrin activation. Differences among 10 molecules in crystal lattices provide unprecedented information on interdomain flexibility important for modelling integrin extension and activation.
我们报告了一个具有αI 结构域的整合素α(X)β(2)的结构,它是补体受体 4 型。此前人们预计,在变构信号传递中,αI 结构域和β-三叶形结构域之间的固定取向是必需的。然而,αI 结构域具有高度的灵活性,能够使两个βI 结构域构象状态与三个αI 结构域状态偶联,并提高配体识别的可及性。尽管α(X)β(2)与缺乏αI 结构域的整合素相似地弯曲,但α 和β 腿的末端结构域,小牛 2 和β-尾巴,的取向与缺乏αI 结构域的整合素不同。延伸到跨膜结构域的接头是无结构的。β(2)-尾巴结构域中的先前突变支持在整合素激活中延伸而不是死锁的重要性。进一步激活突变和抗体表位的位置显示了延伸的关键作用,以及从封闭的头部构象到开放头部构象的转换,在整合素激活中。晶体晶格中 10 个分子之间的差异提供了关于整合素延伸和激活的重要的结构域灵活性的前所未有的信息。
J Cell Biol. 2013-11-25
Proc Natl Acad Sci U S A. 2010-8-2
J Biol Chem. 2018-3-5
Proc Natl Acad Sci U S A. 2012-3-5
J Biol Chem. 2007-4-20
Proc Natl Acad Sci U S A. 2016-3-15
Proc Natl Acad Sci U S A. 2017-3-14
Antioxidants (Basel). 2025-8-16
Front Immunol. 2025-3-4
Immunol Rev. 2025-1
Comput Struct Biotechnol J. 2023-9-18
Front Immunol. 2023
J Appl Crystallogr. 2007-8-1
Nucleic Acids Res. 2007-7
J Biol Chem. 2007-4-20
Annu Rev Immunol. 2007